We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+8.15%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$287B
AUM Growth
+$27.6B
Cap. Flow
+$6.59B
Cap. Flow %
2.29%
Top 10 Hldgs %
12.98%
Holding
8,864
New
808
Increased
4,306
Reduced
2,684
Closed
688

Sector Composition

Rank Sector Weight
1 Technology 9.82%
2 Financials 7.38%
3 Healthcare 6.65%
4 Consumer Discretionary 5.46%
5 Industrials 5.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VPV icon
5551
Invesco Pennsylvania Value Municipal Income Trust
VPV
$200M
$216K ﹤0.01%
16,381
-107
-0.6% -$1.42K
CHMG icon
5552
Chemung Financial Corp
CHMG
$392M
$215K ﹤0.01%
5,071
+1,499
+42% +$65.6K
GO icon
5553
Grocery Outlet
GO
$980M
$215K ﹤0.01%
6,648
-1,241
-16% -$39.9K
GPRK icon
5554
GeoPark
GPRK
$612M
$215K ﹤0.01%
9,747
-12,212
-56% -$232K
MMAC
5555
DELISTED
MMA Capital Holdings, Inc. Common Stock
MMAC
$215K ﹤0.01%
6,770
+2,220
+49% +$70K
NORW
5556
DELISTED
Global X MSCI Norway ETF
NORW
$215K ﹤0.01%
17,182
-3,147
-15% -$37.2K
EGAN icon
5557
eGain
EGAN
$201M
$214K ﹤0.01%
27,084
+9,529
+54% +$73.7K
VTN icon
5558
Invesco Trust for Investment Grade New York Municipals
VTN
$168M
$214K ﹤0.01%
15,768
-1,595
-9% -$21.7K
CURE icon
5559
Direxion Daily Healthcare Bull 3X ETF
CURE
$182M
$213K ﹤0.01%
2,886
-442
-13% -$27K
WLFC icon
5560
Willis Lease Finance
WLFC
$1.29B
$213K ﹤0.01%
10,845
+3,102
+40% +$60.4K
BIO.B icon
5561
Bio-Rad Laboratories Class B
BIO.B
$9.01B
$212K ﹤0.01%
572
HTT
5562
CALL
High Templar Tech Ltd
HTT
$391M
$212K ﹤0.01%
+45,000
New +$265K
UYG icon
5563
ProShares Ultra Financials
UYG
$845M
$212K ﹤0.01%
3,956
+879
+29% +$43.7K
PVLA
5564
Palvella Therapeutics
PVLA
$2.27B
$212K ﹤0.01%
732
+274
+60% +$76K
CAPD
5565
DELISTED
iPath Shiller CAPE ETN
CAPD
$211K ﹤0.01%
+14,150
New +$202K
NHA
5566
DELISTED
Nuveen Municipal 2021 Target Term Fund
NHA
$211K ﹤0.01%
+21,508
New +$210K
BH icon
5567
Biglari Holdings Class B
BH
$1.21B
$210K ﹤0.01%
1,840
+1,067
+138% +$109K
FISK
5568
Empire State Realty OP LP Series 250
FISK
$1.46B
$210K ﹤0.01%
15,234
-2,814
-16% -$39.2K
KNSA icon
5569
Kiniksa Pharmaceuticals
KNSA
$5.93B
$210K ﹤0.01%
18,968
+9,604
+103% +$83.5K
PSO icon
5570
Pearson
PSO
$9.9B
$210K ﹤0.01%
24,979
+2,416
+11% +$20.8K
TELA icon
5571
TELA Bio
TELA
$38.9M
$210K ﹤0.01%
+16,181
New +$198K
LUB
5572
DELISTED
Luby's Inc.
LUB
$210K ﹤0.01%
95,452
+87,452
+1,093% +$177K
PTVCB
5573
DELISTED
Protective Insurance Corporation Class B Common Stock
PTVCB
$210K ﹤0.01%
13,029
+4,426
+51% +$72.1K
CRON
5574
Cronos Group
CRON
$1.14B
$209K ﹤0.01%
27,228
-4,095
-13% -$31.3K
CLPR
5575
Clipper Realty
CLPR
$46.2M
$208K ﹤0.01%
19,569
+5,112
+35% +$48.8K

Similar funds

UBS Group's Q4 2019 Portfolio in Review

As of Q4 2019, UBS Group held 8,864 positions worth $287B, up 11% from $260B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group's Q4 2019 filing shows 808 new, 4,306 increased, 2,684 reduced and 688 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.3B.

By sector, the portfolio is most concentrated in Technology at 9.8% of assets, up from 9.5% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M.
  • UBS Group added most to UBS Group in Q4 2019, an estimated $1.48B increase.
  • UBS Group's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.3B.
  • UBS Group fully exited Altaba Inc in Q4 2019, selling an estimated $759M.
  • UBS Group's ten largest holdings make up 13% of its $287B portfolio in Q4 2019.
  • UBS Group opened 808 new positions and closed 688 in Q4 2019.
  • UBS Group's portfolio value rose 11% quarter-over-quarter to $287B.

Based on UBS Group's 13F filing for Q4 2019, filed 14 Feb 2020.